These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3984323)

  • 21. [Effectiveness of treatment of patients with destructive forms of pulmonary tuberculosis with rifampicin and ethambutol].
    Mavrotskiĭ VV
    Klin Med (Mosk); 1974 Dec; 52(12):31-4. PubMed ID: 4444241
    [No Abstract]   [Full Text] [Related]  

  • 22. [Three-year follow-up results of the first clinical study on the daily and twice-weekly administrations of rifampicin, investigated by the Tuberculosis Research Committee, Ryoken (author's transl)].
    Kekkaku; 1974 Apr; 49(4):107-12. PubMed ID: 4411274
    [No Abstract]   [Full Text] [Related]  

  • 23. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
    Khodashova ML; Iuditskiĭ MV; Semenova OV
    Probl Tuberk Bolezn Legk; 2004; (3):26-8. PubMed ID: 15338896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of patients with destructive pulmonary tuberculosis and nonspecific purulent endobronchitis].
    Pletnev GV; Krasnov VA; Potashova VA
    Probl Tuberk; 2003; (2):33-5. PubMed ID: 12790031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of patients with destructive pulmonary tuberculosis with concomitant diabetes mellitus].
    Giller DB; Kostenko AD; Giller BM; Giller GV
    Probl Tuberk; 2002; (11):18-21. PubMed ID: 12501789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Bacteriological relapse among the previously treated advanced pulmonary tuberculosis patients whose sputum converted to negative by the rifampicin treatment, with special reference to the duration of rifampicin administration (author's transl)].
    Yamamoto M; Morishita M; Hirano Y; Nagata A; Yazaki M
    Kekkaku; 1974 Jul; 49(7):195-9. PubMed ID: 4214961
    [No Abstract]   [Full Text] [Related]  

  • 27. [Ultrasonic therapy of patients with initial diagnosis of pulmonary tuberculosis and long-term destructive changes].
    Gunich LA; Kolesnikova IS
    Probl Tuberk; 1970; 48(11):48-51. PubMed ID: 5516511
    [No Abstract]   [Full Text] [Related]  

  • 28. [Experimental pharmacodynamic study of rifampicin administered by various methods].
    Shapovalov VP; Mil'chenko KP; Kovalenko NN
    Antibiotiki; 1982 Jun; 27(6):434-7. PubMed ID: 7114830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effectiveness of artificial pneumothorax in the treatment of patients with pulmonary tuberculosis with multiple drug-resistant Mycobacteria].
    Chukanov VI; Mishin VIu; Sigaev AT; Vasil'eva IA; Osadchaia OA; Perfil'ev AV; Naumova AN; Bagdasarian TR
    Probl Tuberk Bolezn Legk; 2004; (8):22-4. PubMed ID: 15478553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The pharmacokinetics of rifampicin in the intermittent treatment of patients with pulmonary tuberculosis. 2. The effect of rifampicin on the course of therapy for mycobacteriosis and non-tubercular infectious diseases].
    Eule H; Werner E; Winsel K; Iwainsky H
    Pharmazie; 1985 Apr; 40(4):276-7. PubMed ID: 4011667
    [No Abstract]   [Full Text] [Related]  

  • 31. [Pulmonary tuberculosis in elderly patients].
    Shiraishi Y
    Kyobu Geka; 2005 Jul; 58(8 Suppl):724-8. PubMed ID: 16097626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Rifampicin in the treatment of chronic pulmonary tuberculosis. Preliminary report].
    Pacheco CR; Cordero O; López-Malagón S; Sierra D; De Jesús Pacheco M; Vázquez E
    Gac Med Mex; 1973 Jun; 105(6):541-7. PubMed ID: 4731993
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of newly diagnosed patients with disseminated destructive pulmonary tuberculosis].
    Repnitskaia ZD; Nechaeva OB; Vazhenina OL
    Probl Tuberk; 1984 Oct; (10):55-9. PubMed ID: 6514700
    [No Abstract]   [Full Text] [Related]  

  • 35. [The relation between bacilli negative conversion rate and the number of combined sensitive antituberculous drugs in intermittent administration of rifampicin for severe pulmonary tuberculosis].
    Tamura M; Yamazaki A; Tamura T; Takano S; Yamazaki M
    Kekkaku; 1973 Jul; 48(7):297-302. PubMed ID: 4200058
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effectiveness of pyrazinamide combined with rifampicin and ethambutol in animal experiments].
    Tynystanova RI; Kozlova NV
    Probl Tuberk; 1984 Jul; (7):59-63. PubMed ID: 6483843
    [No Abstract]   [Full Text] [Related]  

  • 37. [Contemporary methods in the diagnosis and treatment of intrathoracic tuberculosis in children].
    Mitinskaia LA; Elufimova VF; Iukhimenko NV; Pogodaeva NP; Iavorskiĭ KM
    Probl Tuberk; 1994; (6):16-8. PubMed ID: 7708637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effectiveness of sanatorium-climatic treatment of destructive in patients pulmonary tuberculosis, aged 50 years and older].
    Navrotskiĭ VV
    Probl Tuberk; 1976 May; (5):33-6. PubMed ID: 133350
    [No Abstract]   [Full Text] [Related]  

  • 39. [Use of rifadin in suppositories in the combined therapy of patients with destructive forms of pulmonary tuberculosis].
    German AK; Syrovatka IuA; Bondarenko VP
    Vrach Delo; 1985 Oct; (10):98-100. PubMed ID: 4090447
    [No Abstract]   [Full Text] [Related]  

  • 40. [Use of anabolic steroids in the complex treatment of patients with destructive pulmonary tuberculosis].
    Bilyk MA
    Vrach Delo; 1985 Mar; (3):19-21. PubMed ID: 4013154
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.